A three-marker panel of CA19-9, CA-125, and HE4 including age as a cofactor was firstly identified for detecting PDAC from benign conditions, including CP and IPMN. This evidence concerns the gene MUC16 and pancreatic intraductal papillary-mucinous neoplasm.